Status:
COMPLETED
Photobiomodulation Therapy on Inflammatory Mediators on Low Back Pain
Lead Sponsor:
Universidade Cidade de Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
University of Bergen
Conditions:
Low Back Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Low back pain (LBP) is ranked as one of the most prevalent health conditions. It is likely that some inflammatory mediators could be associated with pain and disability in these patients. Photobiomodu...
Detailed Description
This is a randomized, triple-blinded (therapist, assessor and patient), placebo-controlled trial, with voluntary patients with non-specific chronic low back pain. Eighteen patients will be randomly a...
Eligibility Criteria
Inclusion
- patients with chronic non-specific low back pain (defined as pain or discomfort between the costal margins and the inferior gluteal folds, with or without referred symptoms in the lower limbs, for at least 3 month);
- with a pain intensity of at least 3 points measured by a 0-10 points pain numerical rating scale;
- aged between 18 and 65 years;
Exclusion
- evidence of nerve root compromise (i.e. one or more of motor, reflex or sensation deficit);
- serious spinal pathology (such as fracture, tumor, inflammatory and infectious diseases);
- serious cardiovascular and metabolic diseases;
- previous back surgery;
- pregnancy.
- severe skin diseases (eg. skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis and severe hives lupus);
Key Trial Info
Start Date :
March 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03859505
Start Date
March 18 2019
End Date
March 29 2019
Last Update
April 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bergen
Bergen, Norway, N-5018